Login

Hassan Wahla, Telenav's Chief Commercial Officer, Delivers Insights on Autonomous Driving in Exclusive Interview | Telenav Inc 00:10:00

Share On Facebook Share On Twitter

Hassan Wahla is the Chief Customer Officer at Telenav

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Fostering Local Talent: Insights from Hillhouse Capital's Lei Zhang | Zhang Lei, CEO , Hillhouse Capital Group.
00:10:00
AXA's Resilient Performance Amidst Geopolitical Uncertainty | Thomas Buberl, CEO , AXA Investment Managers.
00:10:00
Jim Shandalov, Vice President of Origination at NextEra Energy Resources, discusses net zero goals and the energy transition journey.
00:10:00
Henrik Karstensen, CEO of Windon Energy Group, Discusses Q3 2023 Results with Analyst Group | Henrik Karstensen, CEO , Windon Energy Group.
00:10:00
The Benefits of Opening a Roth IRA for Your Child | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
Recapping 2019 & Gauging Recession Fears: Insights from Brandon Zureick and Skye Barry of Johnson Investment Counsel
00:10:00
Exploring Green Metals: Focus on High-Grade Nickel-Copper Projects and Strategic Development
00:10:00
2024 Annual Investment Outlook: Fixed Income and Structured Notes Overview
00:10:00
The Deal Economy - CEO Sam Riley | Sam Riley, CEO, Ansarada Group LtdAND:ASX
00:10:00
The Best VC Pitches Gets Right to the Point|Nick Adams,Co-Founder, Managing Partner,Differential Ventures
00:10:00
Interview with Sean Vokes, CEO of Talisman Mining on Assay TV
00:10:00
Top Absolute Return Performers: Fatima Khizou’s Picks for Consistent Gains Across Market Cycles | Fatima Khizou - Fund Analyst, Morningstar

© 2026 Nehu